Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma

@inproceedings{Zhou2014ExpressionAP,
  title={Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma},
  author={Fei Zhou and Yin-Dong Mu and Jun Liang and Zhi-xin Liu and Hongsheng Chen and Ji-Fei Zhang},
  booktitle={Oncology letters},
  year={2014}
}
The identification of cancer stem cells (CSCs) has improved the understanding of tumor occurrence and development. According to CSC theory, colorectal carcinoma (CRC) may be derived from these few cells. Thus, markers for CSCs may lead to the identification of CSCs and investigation of the correlation with various clinicopathological features and survival time in human CRC patients. Aldehyde dehydrogenase 1 (ALDH1) and CD133 (also known as Prominin-1 or AC133) were involved in the current study… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology • 2016

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Colon cancer stem cells.

Gastrointestinal cancer research : GCR • 2010

International trends in colorectal cancer incidence rates.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2009

: correlation with histologic type and potential precursors

T Nogami, T Shien, +3 authors T Iwamto
2008

Cancer stem cells: a step toward the cure.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2008

Similar Papers

Loading similar papers…